Vise Technologies Inc. Acquires 3,416 Shares of Danaher Corporation $DHR

Vise Technologies Inc. boosted its holdings in Danaher Corporation (NYSE:DHR) by 25.5% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 16,822 shares of the conglomerate’s stock after purchasing an additional 3,416 shares during the period. Vise Technologies Inc.’s holdings in Danaher were worth $3,727,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Marquette Asset Management LLC boosted its holdings in shares of Danaher by 192.1% in the 3rd quarter. Marquette Asset Management LLC now owns 111 shares of the conglomerate’s stock worth $25,000 after buying an additional 73 shares during the last quarter. N.E.W. Advisory Services LLC bought a new position in Danaher during the second quarter valued at about $25,000. Main Street Group LTD purchased a new stake in Danaher during the first quarter worth about $25,000. Field & Main Bank purchased a new stake in Danaher during the second quarter worth about $29,000. Finally, Solstein Capital LLC purchased a new stake in Danaher during the second quarter worth about $33,000. Institutional investors own 79.05% of the company’s stock.

Danaher Trading Up 0.9%

Shares of DHR opened at $229.99 on Wednesday. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The business has a 50-day moving average of $219.38 and a 200 day moving average of $201.70. The firm has a market cap of $161.80 billion, a P/E ratio of 37.64, a price-to-earnings-growth ratio of 2.86 and a beta of 0.76. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.29 and a current ratio of 1.63.

Danaher (NYSE:DHR) last released its quarterly earnings data on Wednesday, October 21st. The conglomerate reported $2.11 EPS for the quarter, beating the consensus estimate of $1.92 by $0.19. The business had revenue of $6.55 billion for the quarter, compared to the consensus estimate of $6.56 billion. Danaher had a net margin of 16.91% and a return on equity of 11.17%. The company’s revenue was up 8.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.89 earnings per share. As a group, research analysts forecast that Danaher Corporation will post 8.59 EPS for the current year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th were given a $0.40 dividend. The ex-dividend date of this dividend was Wednesday, September 30th. This represents a $1.60 annualized dividend and a dividend yield of 0.7%. Danaher’s payout ratio is 26.19%.

Insider Activity

In related news, CAO Christopher Bouda sold 7,598 shares of the company’s stock in a transaction that occurred on Wednesday, October 28th. The shares were sold at an average price of $234.56, for a total transaction of $1,782,186.88. Following the sale, the chief accounting officer directly owned 9,107 shares in the company, valued at approximately $2,136,137.92. This represents a 45.48% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 10.80% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of research firms have weighed in on DHR. Stifel Nicolaus boosted their target price on shares of Danaher from $220.00 to $260.00 and gave the company a “buy” rating in a research note on Thursday, October 22nd. Morgan Stanley increased their target price on shares of Danaher from $220.00 to $240.00 and gave the company an “overweight” rating in a research report on Monday, October 12th. DZ Bank lowered shares of Danaher from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 27th. UBS Group reaffirmed a “buy” rating and issued a $260.00 price target on shares of Danaher in a report on Thursday, October 22nd. Finally, JPMorgan Chase & Co. upped their price objective on Danaher from $250.00 to $270.00 and gave the company an “overweight” rating in a research note on Thursday, October 22nd. Eighteen research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $242.91.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.